Cancer News and Research

Latest Cancer News and Research

Search for prostate cancer biomarkers continues

Collaboration in prostate cancer translational research in Europe is not only vital to sustain the progress achieved in recent years but also to streamline current efforts between researchers and clinicians and avoid duplication or overlaps. This was amongst the goals of the two-day Prostate Cancer Translational Research in Europe (PCTRE) Meeting which opened today in Amsterdam, The Netherlands.

23 Jun 2009

New perspective on the causes, effects and potential treatment of sexual dysfunction

Couples' treatment for sexual problems and other innovative approaches to improving sexual health for men and women are on the agenda of sexual medicine experts.

23 Jun 2009

Biomarker in urine for appendicitis

Appendicitis is the most common childhood surgical emergency, but the diagnosis can be challenging, especially in children, often leading to either unnecessary surgery in children without appendicitis, or a ruptured appendix and serious complications when the condition is missed.

23 Jun 2009

Insurers revoke plans to avoid paying for patients with high costs

A Congressional committee recently turned its attention to rescission, a practice where insurers retroactively revoke plans to avoid paying high costs. NPR reports: "According to a new report by congressional investigators, an insurance company practice of retroactively canceling health insurance is fairly common, and it saves insurers a lot of money.

22 Jun 2009

At VA hospital, a rogue cancer unit

The New York Times reports that a "rogue cancer unit" at a veteran's hospital in Philadelphia "operated with virtually no outside scrutiny and botched 92 of 116 [prostate] cancer treatments over a span of more than six years - and then kept quiet about it, according to interviews with investigators, government officials and public records."

22 Jun 2009

Nine in ten survive early stage bowel cancer

Nine in ten people with bowel cancer that is caught early will survive the disease, according to new statistics published today (Tuesday).

22 Jun 2009

Caucasians more likely to develop Ewing's sarcoma than other races

The largest analysis of its kind has found that Caucasians are much more likely that people in other racial/ethnic groups to develop a rare bone and soft tissue cancer called Ewing's sarcoma. In addition, among Caucasians with this cancer, men are more likely to die than women.

22 Jun 2009

Study exposes tobacco industry's ‘shonky’ behaviour

Researchers in the United States have revealed that tobacco companies have continually changed the ingredients and the design of their cigarettes over time without alerting smokers.

21 Jun 2009

NCRI launches template for sharing research data and samples

The National Cancer Research Institute (NCRI) has launched a broad policy template on sharing research data and biological samples, which will help to streamline the governance requirements for biomedical research which uses such resources.

21 Jun 2009

Researchers develop promising new breast cancer diagnostic marker

Indiana University School of Medicine researchers have developed a new breast cancer diagnostic marker that could enable physicians to more easily determine which patients have a less aggressive form of the disease that may not require chemotherapy treatment.

21 Jun 2009

Frank, Dodd, Grassley speak their minds

Sen. Charles Grassley, R-Iowa, remains on the fence about several provisions in a Democratic plan, The Washington Post reports: "Winning over the Senate Finance Committee's ranking Republican would represent a major coup for Democrats and a rare defection from the GOP party line for Grassley, a populist at heart but a loyal Republican according to his voting record.

21 Jun 2009

Race disparities plague treatment and outcomes in health care

CNN examines race disparities in health care during a 4-minute segment that is part of the station's week-long focus on health care issues.

21 Jun 2009

Antisense Therapeutics trial of ATL1101 in prostate cancer shows promise

Antisense Therapeutics Ltd. (ASX: ANP) has reported further positive results from its collaborative preclinical research studies on the therapeutic potential of ATL1101 in prostate cancer. In experimental models, ATL1101 treatment significantly enhanced the tumor-suppressive effect of the cancer drug Paclitaxel. Paclitaxel is one of a class of drugs known as taxanes.

18 Jun 2009

Targeting tumor behavior may find new anti-cancer agents

Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time.

18 Jun 2009

Improved toxicology test method

Researchers at Oregon State University recently completed the largest animal study ever done in the field of toxicology, and the findings challenge some basic concepts about how to determine what level of a cancer-causing compound can be considered safe.

18 Jun 2009